EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real‐World Assessment of Liver Corrected T1 and Magnetic Resonance Elastography in Predicting Liver Disease Progression

Kathleen E Corey, Nabih Nakrour iD, Emily D Bethea, Jessica E Shay, Karin L Andersson, Irun Bhan, Lawrence S Friedman, Avinash R Kambadakone iD, Laura E Dichtel, Raymond T Chung, Mukesh Harisinghani

Liver International · 2025

DOI: 10.1111/liv.70280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Kathleen E Corey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Division, Liver Center, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Liver Cirrhosis, Liver, Magnetic Resonance Imaging. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical guidelines emphasise identifying patients at risk of chronic liver disease progression. To avoid biopsy drawbacks, noninvasive imaging tests (NITs) have become part of standard‐of‐care. We assessed the real‐world clinical profile, referral trends, and use of magnetic resonance imaging (MRI)‐based tests, multiparametric MRI (mpMRI) and magnetic resonance elastography (MRE), as part of chronic liver disease management.

Methods

Patients referred for abdominal imaging as part of standard‐of‐care were eligible for inclusion irrespective of liver aetiology or referral pathway. Liver fibrosis was assessed using MRE and disease severity using mpMRI (disease activity [iron‐corrected T1, cT1], liver fat content [LFC] and iron). T ‐tests were used for group comparisons; Kaplan–Meier analyses for disease progression and area under the receiver operating characteristic (AUC) for diagnostic accuracy.

Results

Over 18 months, 256 patients (53 years, 51% female, 48% with BMI > 30 kg/m 2 ) were referred for liver imaging. The majority (66%) had steatotic liver disease (SLD). Of those with low MRE (73%) and low FIB‐4 (42%), 36% had elevated cT1 (> 875 ms). Those with MRE > 5 kPa had cT1 > 875 ms. During follow‐up, those with low MRE (< 3.14 kPa) but elevated cT1 (> 800 ms) had significant disease worsening (HR: 3.1, p = 0.0035) compared to all others. In the SLD group, cT1 (AUC: 0.71) outperformed LFC (AUC: 0.64) and MRE (AUC: 0.53) in predicting disease progression.

Conclusion

Regardless of aetiology, patients with low fibrosis risk (MRE) but high disease activity (cT1) face a three‐times higher risk of progression. Integrating both biomarkers into standard care, especially for SLD, can guide management adjustments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Elasticity Imaging TechniquesLiver CirrhosisLiverMagnetic Resonance ImagingHumansFemaleDisease ProgressionMaleMiddle AgedAdultAgedSeverity of Illness IndexROC CurveMultiparametric Magnetic Resonance ImagingPredictive Value of TestsRetrospective Studies

Stichwörter der Autor:innen

chronic liver diseasenoninvasive testspatient managementprognosticreal‐world

Autor:innen und Institutionen

  • Gastroenterology Division, Liver Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Radiology Department, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Medicine, Newton-Wellesley Hospital, Newton, Massachusetts, USA.
  • Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Neuroendocrinology Department, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Nabih Nakrour, Avinash R Kambadakone

Zitieren

APA

Corey, K. E., Nakrour, N., Bethea, E. D., Shay, J. E., Andersson, K. L., Bhan, I., Friedman, L. S., Kambadakone, A. R., Dichtel, L. E., Chung, R. T., & Harisinghani, M. (2025). Real‐World Assessment of Liver Corrected T1 and Magnetic Resonance Elastography in Predicting Liver Disease Progression. Liver International. https://doi.org/10.1111/liv.70280

Vancouver

Corey KE, Nakrour N, Bethea ED, Shay JE, Andersson KL, Bhan I, et al. Real‐World Assessment of Liver Corrected T1 and Magnetic Resonance Elastography in Predicting Liver Disease Progression. Liver International. 2025. doi:10.1111/liv.70280

BibTeX
@article{Corey2025,
  author = {Corey, Kathleen E and Nakrour, Nabih and Bethea, Emily D and Shay, Jessica E and Andersson, Karin L and Bhan, Irun and Friedman, Lawrence S and Kambadakone, Avinash R and Dichtel, Laura E and Chung, Raymond T and Harisinghani, Mukesh},
  title = {Real‐World Assessment of Liver Corrected T1 and Magnetic Resonance Elastography in Predicting Liver Disease Progression},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70280}
}
Kostenlos starten →